Method of determining endometrial receptivity
View Patent ↗The present invention provides a method of predicting the probability of a successful pregnancy, either a naturally achieved pregnancy or a pregnancy resulting from an assisted reproductive technology, based on the level of L-selectin ligand expressed by uterine epithelial cells and/or the level of L-selectin expressed by an embryo in vitro. The invention further provides methods of inhibiting cell adhesion between a trophoblast and a uterine epithelial cell. Methods of inhibiting cell adhesion between a trophoblast and a uterine epithelial cell are useful to inhibit pregnancy. The invention further provides methods of assessing in vitro embryo quality. The invention further provides methods of predicting the probability of continued success of a pregnancy during the first 16 weeks of gestation.
1. A method of determining the probability of success of implantation in a female human following an assisted reproductive technology or naturally achieved conception, the method comprising:
determining the level of an L-selectin ligand carbohydrate epitope that is produced by a uterine epithelial cell, and that is present in a biological sample from the female human, wherein the L-selectin ligand carbohydrate epitope comprises one or more carbohydrate epitopes selected from SO 3 →6G1cNAc, sLe x (Siaα2→3Ga1β1→4[Fucα1→3]G1cNAc), 6-sulfo sLe x (Siaα2→3Ga1β1→4[Fucα1→3][SO 3 →6]G1cNAc), 6′-sulfo sLe x (Siaα2→3[SO 3 →6]Ga1→4[Fucα1→3]G1cNAc), and6′,6-disulfo sLe x (Siaα2→3[SO 3 →6]Ga1β1→4[Fucα1→3][SO 3 →6]G1cNAc);
comparing the level to a standard; and
determining the probability of success of implantation following an assisted reproductive technology or naturally achieved conception based on the level of an L-selectin ligand carbohydrate epitope produced by the uterine epithelial cell, wherein an increase in the level of the L-selectin ligand carbohydrate epitope, compared to a control level, indicates an increased probability of success of implantation.
2. The method of claim 1 , wherein the biological sample is selected from the group consisting of a uterine biopsy sample, a uterine fluid sample, a vaginal fluid sample, saliva, and maternal blood.
3. The method of claim 1 , wherein the assisted reproductive technology is selected from the group consisting of in vitro fertilization, embryo transfer, gamete intrafallopian transfer, tubal embryo transfer, intracytoplasmic sperm injection, and intrauterine insemination.
4. The method of claim 1 , wherein the L-selectin ligand carbohydrate epitope is detected with an immunological assay using an antibody specific for the L-selectin ligand carbohydrate epitope.
5. The method of claim 4 , wherein the antibody is detectably labeled.
6. The method of claim 1 , wherein the L-selectin ligand carbohydrate epitope is sulfated.